BioStem Technologies to Present at Two Upcoming Investor Conferences
BioStem Technologies (OTC:BSEM), a MedTech company specializing in placental-derived biologics for advanced wound care, has announced its participation in two upcoming investor conferences in New York.
The company will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on September 8, 2025, at 3:20 PM ET, followed by a presentation at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025, at 11:00 AM ET. Investors can access live and archived webcasts of both presentations through BioStem's investor relations website.
BioStem Technologies (OTC:BSEM), societ脿 MedTech specializzata in biologici derivati dalla placenta per la gestione avanzata delle ferite, ha annunciato la sua partecipazione a due prossimi convegni per investitori a New York.
La societ脿 terr脿 una fireside chat al Morgan Stanley Global Healthcare Conference l'8 settembre 2025 alle 15:20 ET, seguita da una presentazione al H.C. Wainwright 27th Annual Global Investment Conference il 9 settembre 2025 alle 11:00 ET. Gli investitori potranno seguire le trasmissioni in diretta e gli archivi video di entrambe le presentazioni tramite il sito web delle relazioni con gli investitori di BioStem.
BioStem Technologies (OTC:BSEM), una empresa MedTech especializada en biol贸gicos derivados de la placenta para el cuidado avanzado de heridas, ha anunciado su participaci贸n en dos pr贸ximas conferencias para inversores en Nueva York.
La compa帽铆a participar谩 en una charla informal (fireside chat) en la Morgan Stanley Global Healthcare Conference el 8 de septiembre de 2025 a las 3:20 PM ET, seguida de una presentaci贸n en la H.C. Wainwright 27th Annual Global Investment Conference el 9 de septiembre de 2025 a las 11:00 AM ET. Los inversores podr谩n acceder a las retransmisiones en directo y a las grabaciones de ambas presentaciones a trav茅s del sitio web de relaciones con inversores de BioStem.
BioStem Technologies (OTC:BSEM)電� 瓿犼笁 靸侅矘 旃橂鞖� 韮滊皹 鞙犽灅 靸濍頃欖牅鞐� 韸鬼檾霅� 氅旊摐韰岉伂 旮办梾鞙茧, 雺挫殨鞐愳劀 鞐措Μ電� 霊� 瓯挫潣 韴瀽鞛� 旎嵓霟办姢鞐� 彀戈皜頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟.
須岇偓電� 2025雲� 9鞗� 8鞚� 鞓ろ泟 3鞁� 20攵�(ET)鞐� 鞐措Μ電� Morgan Stanley Global Healthcare Conference鞚� 韺岇澊鞏挫偓鞚措摐 毂勴姼鞐� 彀胳棳頃橁碃, 鞚挫柎 2025雲� 9鞗� 9鞚� 鞓れ爠 11鞁�(ET)鞐� 鞐措Μ電� H.C. Wainwright 27th Annual Global Investment Conference鞐愳劀 氚滍憸毳� 歆勴枆頃� 鞓堨爼鞛呺媹雼�. 韴瀽鞛愲摛鞚� BioStem 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼毳� 韱淀暣 霊� 氚滍憸鞚� 靸濎瓿� 氚� 雲鬼檾 鞓侅儊鞚� 鞁滌箔頃� 靾� 鞛堨姷雼堧嫟.
BioStem Technologies (OTC:BSEM), une soci茅t茅 MedTech sp茅cialis茅e dans les produits biologiques d茅riv茅s du placenta pour les soins avanc茅s des plaies, a annonc茅 sa participation 脿 deux prochaines conf茅rences investisseurs 脿 New York.
L'entreprise prendra part 脿 une discussion informelle (fireside chat) lors de la Morgan Stanley Global Healthcare Conference le 8 septembre 2025 脿 15h20 ET, puis donnera une pr茅sentation lors de la H.C. Wainwright 27th Annual Global Investment Conference le 9 septembre 2025 脿 11h00 ET. Les investisseurs pourront acc茅der aux webcasts en direct et aux archives des deux pr茅sentations via le site relations investisseurs de BioStem.
BioStem Technologies (OTC:BSEM), ein MedTech-Unternehmen, das sich auf plazenta-abgeleitete Biologika f眉r die fortgeschrittene Wundversorgung spezialisiert hat, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen in New York angek眉ndigt.
Das Unternehmen wird am 8. September 2025 um 15:20 Uhr ET an einem Fireside-Chat auf der Morgan Stanley Global Healthcare Conference teilnehmen und am 9. September 2025 um 11:00 Uhr ET eine Pr盲sentation auf der H.C. Wainwright 27th Annual Global Investment Conference halten. Investoren k枚nnen Live-脺bertragungen und Archivaufnahmen beider Pr盲sentationen 眉ber die Investor-Relations-Website von BioStem abrufen.
- None.
- None.
POMPANO BEACH, Fla., Sept. 02, 2025 (GLOBE NEWSWIRE) -- (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announced that Company management will present at the following upcoming investor conferences being held in New York, NY.
Morgan Stanley Global Healthcare Conference:
- Format: Fireside Chat
- Date: Monday, September 8, 2025
- Time: 3:20 PM ET
H.C. Wainwright 27th Annual Global Investment Conference:
- Format: Presentation
- Date: Tuesday, September 9, 2025
- Time: 11:00 AM ET
Interested parties may access live and archived webcasts of the presentations on the 鈥渋nvestors鈥� section of the Company鈥檚 website at: .听
Join BioStem鈥檚 Distribution List & Social Media:
To follow the latest developments at BioStem, sign-up to the Company鈥檚 email distribution list , and follow us on and .
About BioStem Technologies, Inc.听(OTC: BSEM): BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioREtain庐听processing method. BioREtain庐听has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies鈥� quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks (鈥淎ATB鈥�). These systems and procedures are established per current Good Tissue Practices (鈥渃GTP鈥�) and current Good Manufacturing Processes (鈥渃GMP鈥�). Our portfolio of quality brands includes AmnioWrap2鈩�, VENDAJE庐, VENDAJE AC庐, and VENDAJE OPTIC庐. Each BioStem Technologies placental allograft is processed at the Company鈥檚 FDA registered and AATB accredited site in Pompano Beach, Florida. For more information visit and follow us on and .
Contact BioStem Technologies, Inc.:
奥别产蝉颈迟别:听
贰-惭补颈濒:听
齿:听
贵补肠别产辞辞办:听
Phone: 954-380-8342
Investor Relations:
Adam Holdsworth, BioStem Director of Investor Relations
贰-惭补颈濒:听
笔丑辞苍别:听917-497-9287
Or
Gilmartin Group
Philip Trip Taylor, Principal
贰-惭补颈濒:听
Phone: 415-937-5406
FAQ
When is BioStem Technologies (BSEM) presenting at the Morgan Stanley Global Healthcare Conference 2025?
What is the format of BioStem's presentation at the H.C. Wainwright Conference 2025?
Where can investors watch BioStem Technologies' conference presentations?
What is BioStem Technologies' main business focus?
